Erschienen in:
01.06.2019 | editorial
Saving lives with lung cancer screening
Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2019
Einloggen, um Zugang zu erhaltenExcerpt
Lung cancer is the number one reason for cancer-related death in Austria and many other countries, especially due the fact that the majority of patients are diagnosed at an advanced stage of the disease. Two large trials (NLST and NELSON) proved the efficacy of low-dose CT (LD-CT) for lung cancer screening [ 1, 2]. Lung cancer deaths were decreased and early diagnosis facilitated curative treatment options. Thus, the risk to die from lung cancer was reduced by 26% in the NELSON trial. …Anzeige